Article
Genetic moderators of naltrexone's effects on alcohol cue reactivity.
Alcoholism, clinical and experimental research - 1 Aug 2006
McGeary John E, Monti Peter M, Rohsenow Damaris J, Tidey Jennifer, Swift Robert, Miranda Robert
Abstract excerpt
BACKGROUND: Naltrexone (NTX) reduces drinking and craving in alcoholic individuals in treatment and also in heavy drinkers. Polymorphisms in the D4 dopamine receptor (DRD4) gene and mu-opiate receptor gene (OPRM1) may moderate NTX's effects on craving. This study examined these candidate genes as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
